Clinical Trial Update: Omentopexy With Glubran®2 for Reducing Complications After Sleeve Gastrectomy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating omentopexy with Glubran 2 to reduce complications after sleeve gastrectomy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Glubran 2 (cyanoacrylate-based surgical adhesive)

Snippet

Sponsor: University of Salerno | Conditions: Obesity With BMI >35 | Phase 4 | Status: COMPLETED